The American Society of Addiction Medicine has released the first clinical guide and national resource for managing the intoxication and withdrawal of medetomidine.
|Poll|December 7, 2017
Mini Quiz: Prescribing for Patients With SUDS
Author(s)George Dawson, MD
What should prescribers of controlled substances keep in mind when working with patients with substance use disorders? Take the quiz and learn more.
Advertisement
The British National Formulary suggests practical points that every practitioner should keep in mind when prescribing medications with an addictive potential. Which of the following points is not correct?
Advertisement
Related to this article
New data shows cannabis dominates teens’ substance-related ER visits, often with alcohol or stimulants, urging better screening and intervention for psychosis, vomiting.
GLP-1 drugs enter psychiatry, curbing antipsychotic weight gain while raising new questions about addiction, mood, eating disorders, and culture.
Miss Golden Corner 2026 discusses the South Carolina campus naloxone law she helped start and her push to reduce addiction stigma in rural communities.
National survey shows most US adults don’t know AUD medications exist, and safety concerns plus racial disparities shape hesitation toward treatment.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
2
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
3
Lumateperone Shows Significant and Rapid Improvement in Bipolar Mania
4
Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia
5